Fertility Preservation with Immature and in Vitro Matured Oocytes

 

 Buy Article Permissions and Reprints

ABSTRACT

The development of an effective oocyte-freezing program will have a major impact on clinical practice in reproductive medicine and will serve as a powerful tool to preserve fertility for teenage girls and young women without male partners or for those individuals who are affected by malignancies. It will also be beneficial to infertile couples who have moral or religious objections about embryo cryopreservation. In addition, a successful oocyte cryopreservation program will eliminate the need for donor and recipient menstrual cycle synchronization and will enable the establishment of oocyte banks, which would facilitate the logistics of coordinating egg donors with recipients. Recent advances in vitrification technology have markedly improved the oocyte survival rate after thawing, and the pregnancy rate is comparable with that achieved with fresh oocytes. However, most studies were performed using in vivo matured oocytes for vitrification. The objective of this article was to review whether immature and in vitro matured human oocytes can be vitrified successfully. The results indicated that although healthy live births can be achieved from the combination of in vitro maturation (IVM) oocytes and vitrification, vitrification of in vitro matured oocytes is less effective than vitrification of in vivo matured oocytes. The results suggest that oocytes should be vitrified at the mature metaphase II stage following IVM rather than at the immature germinal vesicle (GV) stage because the potential of oocyte maturation is reduced by the vitrification of immature oocytes at the GV stage.

REFERENCES

• 1 American Cancer Society .Cancer Facts and Figures—2001. Atlanta, GA; American Cancer Society 2001
  PubMedGoogle Scholar
• 2 Ries L AG, Percy C L, Bunin G R. Introduction. In: Ries LAG, Smith MA, Gurney JG, et al Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995 (NIH Pub. No. 99–4649). Bethesda, MD; National Cancer Institute 1999: 1-15
  PubMedGoogle Scholar
• 3 Donnez J, Dolmans M M, Demylle D et al.. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue.  Lancet. 2004;  364(9443) 1405-1410
  CrossrefPubMedGoogle Scholar
• 4 Meirow D, Levron J, Eldar-Geva T et al.. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy.  N Engl J Med. 2005;  353(3) 318-321
  CrossrefPubMedGoogle Scholar
• 5 Kuleshova L, Gianaroli L, Magli C, Ferraretti A, Trounson A. Birth following vitrification of a small number of human oocytes: case report.  Hum Reprod. 1999;  14(12) 3077-3079
  CrossrefPubMedGoogle Scholar
• 6 Yoon T K, Kim T J, Park S E et al.. Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program.  Fertil Steril. 2003;  79 1323-1326
  CrossrefPubMedGoogle Scholar
• 7 Katayama K P, Stehlik J, Kuwayama M, Kato O, Stehlik E. High survival rate of vitrified human oocytes results in clinical pregnancy.  Fertil Steril. 2003;  80(1) 223-224
  PubMedGoogle Scholar
• 8 Kuleshova L L, Lopata A. Vitrification can be more favorable than slow cooling.  Fertil Steril. 2002;  78(3) 449-454
  CrossrefPubMedGoogle Scholar
• 9 Chian R C, Lim J H, Tan S L. State of the art in in-vitro oocyte maturation.  Curr Opin Obstet Gynecol. 2004;  16(3) 211-219
  CrossrefPubMedGoogle Scholar
• 10 Luyet B. The vitrification of organic colloids and protoplasm.  Biodynamica. 1937;  1 1-14
  PubMedGoogle Scholar
• 11 Kasai M, Zhu S E, Pedro P B, Nakamura K, Sakurai T, Edashige K. Fracture damage of embryos and its prevention during vitrification and warming.  Cryobiology. 1996;  33(4) 459-464
  CrossrefPubMedGoogle Scholar
• 12 Cao Y X, Xing Q, Li L et al.. Comparison of survival and embryonic development in human oocytes cryopreserved by slow-freezing and vitrification.  Fertil Steril. 2008;  , October 16 (Epub ahead of print)
  PubMedGoogle Scholar
• 13 Ali J, Shelton J N. Vitrification of preimplantation stages of mouse embryos.  J Reprod Fertil. 1993;  98(2) 459-465
  PubMedGoogle Scholar
• 14 Mukaida T, Wada S, Takahashi K, Pedro P B, An T Z, Kasai M. Vitrification of human embryos based on the assessment of suitable conditions for 8-cell mouse embryos.  Hum Reprod. 1998;  13(1O) 2874-2879
  PubMedGoogle Scholar
• 15 Kuleshova L L, Shaw J M. A strategy for rapid cooling of embryos within a double straw to eliminate the risk of contamination during cryopreservation and storage.  Hum Reprod. 2000;  15 2604-2609
  CrossrefPubMedGoogle Scholar
• 16 Kasai M, Komi J H, Takakamo A, Tsudera H, Sakurai T, Machida T. A simple method for mouse embryo cryopreservation in a low toxicity vitrification solution, without appreciable loss of viability.  J Reprod Fertil. 1990;  89(1) 91-97
  CrossrefPubMedGoogle Scholar
• 17 Vajta G, Holm P, Kuwayama M et al.. Open Pulled Straw (OPS) vitrification: a new way to reduce cryoinjuries of bovine ova and embryos.  Mol Reprod Dev. 1998;  51(1) 53-58
  CrossrefPubMedGoogle Scholar
• 18 Chian R C, Kuwayama M, Tan L, Tan J, Kato O, Nagai T. High survival rate of bovine oocytes matured in vitro following vitrification.  J Reprod Dev. 2004;  50(6) 685-696
  CrossrefPubMedGoogle Scholar
• 19 Chian R C, Son W Y, Huang J et al.. High survival rates and pregnancies of human oocytes following vitrification: preliminary report.  Fertil Steril. 2005;  84 S36
  PubMedGoogle Scholar
• 20 Kuwayama M, Vajta G, Ieda S, Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination.  Reprod Biomed Online. 2005;  11(5) 608-614
  CrossrefPubMedGoogle Scholar
• 21 Lane M, Bavister B D, Lyons E A, Forest K T. Containerless vitrification of mammalian oocytes and embryos.  Nat Biotechnol. 1999;  17(12) 1234-1236
  CrossrefPubMedGoogle Scholar
• 22 Lane M, Schoolcraft W B, Gardner D K. Vitrification of mouse and human blastocysts using a novel cryoloop container-less technique.  Fertil Steril. 1999;  72(6) 1073-1078
  CrossrefPubMedGoogle Scholar
• 23 Vajta G, Holm P, Kuwayama M et al.. Open Pulled Straw (OPS) vitrification: a new way to reduce cryoinjuries of bovine ova and embryos.  Mol Reprod Dev. 1998;  51(1) 53-58
  CrossrefPubMedGoogle Scholar
• 24 Vanderzwalmen P, Bertin G, Debauche Ch et al.. Vitrification of human blastocysts with the Hemi-Straw carrier: application of assisted hatching after thawing.  Hum Reprod. 2003;  18(7) 1504-1511
  CrossrefPubMedGoogle Scholar
• 25 Martino A, Songsasen N, Leibo S P. Development into blastocysts of bovine oocytes cryopreserved by ultra-rapid cooling.  Biol Reprod. 1996;  54(5) 1059-1069
  CrossrefPubMedGoogle Scholar
• 26 Mukaida T, Nakamura S, Tomiyama T, Wada S, Kasai M, Takahashi K. Successful birth after transfer of vitrified human blastocysts with use of a cryoloop containerless technique.  Fertil Steril. 2001;  76(3) 618-620
  CrossrefPubMedGoogle Scholar
• 27 Hong S W, Chung H M, Lim J M et al.. Improved human oocyte development after vitrification: a comparison of thawing methods.  Fertil Steril. 1999;  72(1) 142-146
  CrossrefPubMedGoogle Scholar
• 28 Yokota Y, Yokota H, Yokota M, Sato S, Araki Y. Birth of healthy twins from in vitro development of human refrozen embryos.  Fertil Steril. 2001;  76(5) 1063-1065
  CrossrefPubMedGoogle Scholar
• 29 Chung H M, Hong S W, Lim J M et al.. In vitro blastocyst formation of human oocytes obtained from unstimulated and stimulated cycles after vitrification at various maturational stages.  Fertil Steril. 2000;  73(3) 545-551
  CrossrefPubMedGoogle Scholar
• 30 Chi H J, Koo J J, Kim M Y, Joo J Y, Chang S S, Chung K S. Cryopreservation of human embryos using ethylene glycol in controlled slow freezing.  Hum Reprod. 2002;  17(8) 2146-2151
  CrossrefPubMedGoogle Scholar
• 31 Cho H J, Son W Y, Yoon S H, Lee S W, Lim J H. An improved protocol for dilution of cryoprotectants from vitrified human blastocysts.  Hum Reprod. 2002;  17(9) 2419-2422
  CrossrefPubMedGoogle Scholar
• 32 Son W Y, Yoon S H, Yoon H J, Lee S M, Lim J H. Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele.  Hum Reprod. 2003;  18(1) 137-139
  CrossrefPubMedGoogle Scholar
• 33 Yoon T K, Kim T J, Park S E et al.. Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program.  Fertil Steril. 2003;  79 1323-1326
  CrossrefPubMedGoogle Scholar
• 34 Katayama K P, Stehlik J, Kuwayama M, Kato O, Stehlik E. High survival rate of vitrified human oocytes results in clinical pregnancy.  Fertil Steril. 2003;  80(1) 223-224
  PubMedGoogle Scholar
• 35 Kyono K, Fuchinoue K, Yagi A et al.. Successful pregnancy and delivery after transfer of a single blastocyst derived from a vitrified mature human oocyte.  Fertil Steril. 2004;  84 1017
  PubMedGoogle Scholar
• 36 Chen C. Pregnancy after human oocyte cryopreservation.  Lancet. 1986;  1 884-886
  PubMedGoogle Scholar
• 37 Tucker M, Wright G, Morton P, Shanguo L, Massey J, Kort H. Preliminary experience with human oocyte cryopreservation using 1,2-propanediol and sucrose.  Hum Reprod. 1996;  11(7) 1513-1515
  PubMedGoogle Scholar
• 38 Porcu E, Fabbri R, Seracchioli R, Ciotti P M, Magrini O, Flamigni C. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes.  Fertil Steril. 1997;  68(4) 724-726
  CrossrefPubMedGoogle Scholar
• 39 Yang D S, Blohm P L, Winslow K L et al.. A twin pregnancy after microinjection of human cryopreserved oocyte with a specially developed oocyte cryopreservation regime.  Fertil Steril. 1998;  70(suppl 1) S86
  PubMedGoogle Scholar
• 40 Stachecki J J, Cohen J, Willadsen S M. Cryopreservation of unfertilized mouse oocytes: the effect of replacing sodium with choline in the freezing medium.  Cryobiology. 1998;  37(4) 346-354
  CrossrefPubMedGoogle Scholar
• 41 Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S, Flamigni C. Human oocyte cryopreservation: new perspectives regarding oocyte survival.  Hum Reprod. 2001;  16(3) 411-416
  CrossrefPubMedGoogle Scholar
• 42 Quintans C J, Donaldson M J, Bertolino M V, Pasqualini R S. Birth of two babies using oocytes that were cryopreserved in a choline-based freezing medium.  Hum Reprod. 2002;  17(12) 3149-3152
  CrossrefPubMedGoogle Scholar
• 43 Boldt J, Cline D, McLaughlin D. Human oocyte cryopreservation as an adjunct to IVF-embryo transfer cycles.  Hum Reprod. 2003;  18(6) 1250-1255
  CrossrefPubMedGoogle Scholar
• 44 Boldt J, Tidswell N, Sayers A, Kilani R, Cline D. Human oocyte cryopreservation: 5-year experience with a sodium-depleted slow freezing method.  Reprod Biomed Online. 2006;  13(1) 96-100
  CrossrefPubMedGoogle Scholar
• 45 Borini A, Bonu M A, Coticchio G, Bianchi V, Cattoli M, Flamigni C. Pregnancies and births after oocyte cryopreservation.  Fertil Steril. 2004;  82(3) 601-605
  CrossrefPubMedGoogle Scholar
• 46 Borini A, Sciajno R, Bianchi V, Sereni E, Flamigni C, Coticchio G. Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration.  Hum Reprod. 2006;  21(2) 512-517
  PubMedGoogle Scholar
• 47 Stachecki J J, Cohen J. An overview of oocyte cryopreservation.  Reprod Biomed Online. 2004;  9(2) 152-163
  CrossrefPubMedGoogle Scholar
• 48 Azambuja R, Badalotti M, Teloken C, Michelon J, Petracco A. Successful birth after injection of frozen human oocytes with frozen epididymal spermatozoa.  Reprod Biomed Online. 2005;  11(4) 449-451
  CrossrefPubMedGoogle Scholar
• 49 Bianchi V, Coticchio G, Fava L, Flamigni C, Borini A. Meiotic spindle imaging in human oocytes frozen with a slow freezing procedure involving high sucrose concentration.  Hum Reprod. 2005;  20(4) 1078-1083
  PubMedGoogle Scholar
• 50 Coticchio G, Bonu M A, Bianchi V, Flamigni C, Borini A. Criteria to assess human oocyte quality after cryopreservation.  Reprod Biomed Online. 2005;  11(4) 421-427
  CrossrefPubMedGoogle Scholar
• 51 Levi Setti P E, Albani E, Novara P V, Cesana A, Morreale G. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles.  Hum Reprod. 2006;  21(2) 370-375
  PubMedGoogle Scholar
• 52 Cooper A, Paynter S J, Fuller B J, Shaw R W. Differential effects of cryopreservation on nuclear or cytoplasmic maturation in vitro in immature mouse oocytes from stimulated ovaries.  Hum Reprod. 1998;  13(4) 971-978
  CrossrefPubMedGoogle Scholar
• 53 Isachenko E F, Nayudu P L. Vitrification of mouse germinal vesicle oocytes: effect of treatment temperature and egg yolk on chromatin and spindle normality and cumulus integrity.  Hum Reprod. 1999;  14(2) 400-408
  CrossrefPubMedGoogle Scholar
• 54 Toth T L, Lanzendorf S E, Sandow B A et al.. Cryopreservation of human prophase I oocytes collected from unstimulated follicles.  Fertil Steril. 1994;  61(6) 1077-1082
  PubMedGoogle Scholar
• 55 Toth T L, Baka S G, Veeck L L, Jones Jr H W, Muasher S, Lanzendorf S E. Fertilization and in vitro development of cryopreserved human prophase I oocytes.  Fertil Steril. 1994;  61(5) 891-894
  PubMedGoogle Scholar
• 56 Son W Y, Park S E, Lee K A et al.. Effects of 1,2-propanediol and freezing-thawing on the in vitro developmental capacity of human immature oocytes.  Fertil Steril. 1996;  66(6) 995-999
  PubMedGoogle Scholar
• 57 Tucker M J, Wright G, Morton P C, Massey J B. Birth after cryopreservation of immature oocytes with subsequent in vitro maturation.  Fertil Steril. 1998;  70(3) 578-579
  CrossrefPubMedGoogle Scholar
• 58 Chian R C. In-vitro maturation of immature oocytes for infertile women with PCOS.  Reprod Biomed Online. 2004;  8 547-552
  CrossrefPubMedGoogle Scholar
• 59 Chian R C, Lim J H, Tan S L. State of the art in in-vitro oocyte maturation.  Curr Opin Obstet Gynecol. 2004;  16(3) 211-219
  CrossrefPubMedGoogle Scholar
• 60 Le Du A, Kadoch I J, Bourcigaux N et al.. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience.  Hum Reprod. 2005;  20(2) 420-424
  CrossrefPubMedGoogle Scholar
• 61 Jurema M W, Nogueira D. In vitro maturation of human oocytes for assisted reproduction.  Fertil Steril. 2006;  86(5) 1277-1291
  CrossrefPubMedGoogle Scholar
• 62 Gunby J, Daya S. IVF Directors Group of the Canadian Fertility and Andrology Society . Assisted reproductive technologies (ART) in Canada: 2003 results from the Canadian ART Register.  Fertil Steril. 2007;  88(3) 550-559
  CrossrefPubMedGoogle Scholar
• 63 Centers for Disease Control and Prevention .2003 assisted reproductive technology (ART) report: section 2—ART cycles using fresh, nondonor eggs or embryos (updated March 27, 2006; cited on October 19, 2006). Available from: http://www.cdc.gov/ART/ART2003/sect2_fig3-13.htm#Figure%2010 Accessed March 29, 2007
  PubMedGoogle Scholar
• 64 Andersen A N, Gianaroli L, Felberbaum R, de Mouzon J, Nygren K G. European IVF-monitoring programme (EIM) for the European Society of Human Reproduction and Embryology (ESHRE) . Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE.  Hum Reprod. 2006;  21(7) 1680-1697
  CrossrefPubMedGoogle Scholar
• 65 Buckett W M, Chian R C et al.. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection.  Obstet Gynecol. 2007;  110 885-891
  CrossrefPubMedGoogle Scholar
• 66 Brinsden P R, Wada I, Tan S L, Balen A, Jacobs H S. Diagnosis, prevention and management of ovarian hyperstimulation syndrome.  Br J Obstet Gynaecol. 1995;  102(10) 767-772
  PubMedGoogle Scholar
• 67 Tan S L, Maconochie N, Doyle P et al.. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin.  Am J Obstet Gynecol. 1994;  171(2) 513-520
  PubMedGoogle Scholar
• 68 Venn A, Jones P, Quinn M, Healy D. Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients.  Gynecol Oncol. 2001;  82(1) 64-68
  CrossrefPubMedGoogle Scholar
• 69 Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation.  Lancet. 1999;  354(9190) 1586-1590
  CrossrefPubMedGoogle Scholar
• 70 Rao G D, Chian R C, Son W S, Gilbert L, Tan S L. Fertility preservation in women undergoing cancer treatment.  Lancet. 2004;  363(9423) 1829-1830
  PubMedGoogle Scholar
• 71 Bines J, Oleske D M, Cobleigh M A. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.  J Clin Oncol. 1996;  14(5) 1718-1729
  PubMedGoogle Scholar
• 72 Partridge A H, Gelber S, Peppercorn J et al.. Web-based survey of fertility issues in young women with breast cancer.  J Clin Oncol. 2004;  22(20) 4174-4183
  CrossrefPubMedGoogle Scholar
• 73 Gook D A, Edgar D H. Human oocyte cryopreservation.  Hum Reprod Update. 2007;  13(6) 591-605
  CrossrefPubMedGoogle Scholar
• 74 Fahy G M. Theoretical considerations for oocyte cryopreservation by freezing.  Reprod Biomed Online. 2007;  14(6) 709-714
  CrossrefPubMedGoogle Scholar
• 75 De Santis L, Cino I, Coticchio G et al.. Objective evaluation of the viability of cryopreserved oocytes.  Reprod Biomed Online. 2007;  15(3) 338-345
  CrossrefPubMedGoogle Scholar

Ri-Cheng ChianPh.D. 

Royal Victoria Hospital Women's Pavilion F3-36

687 Pine Avenue West, Montreal, Quebec, Canada H3A 1A1

Email: ri-cheng.chian@muhc.mcgill.ca